10/16/2026
Revolution Medicines, co-founded by Beckman’s Martin Burke, also of Carle Illinois College of Medicine, makes a pancreatic cancer drug that nearly doubled median survival in a Phase 3 trial. The FDA approved the drug on Aug. 26.
While helping to launch the world’s first engineering-based college of medicine, Carle Illinois College of Medicine’s Inaugural Associate Dean for Research, Martin Burke, also co-founded a company that has given new hope to patients with advanced pancreatic cancer. Revolution Medicines, original...